The goal of this project is to determine the molecular mechanism by which two abused drugs, nicotine and cocaine, interact with neuronal nicotinic acetylcholine receptors (nAChRs) in the peripheral and central nervous systems. Cocaine exerts its euphoric, addictive nature through the dopamine transport system, but some of its toxic effects may occur by way of some subtypes of neuronal nAChRs. nAChRs regulate signal transmission between many central nervous system neurons and at the neuromuscular junction, and both nicotine and cocaine affect their function. Reports in the literature have suggested that cocaine and other local anesthetics, when administered intraventricularly, are antagonistic to the behavioral and pharmacological effects of nicotine.
The aim of this proposal is to determine the chemical mechanism of by which nicotine activates and cocaine inhibits neuronal nAChRs expressed in Xenopus oocytes. Preliminary results have demonstrated that different neuronal nicotinic receptor subtypes are differentially affected by cocaine. The affinity of cocaine for some neuronal subtypes is well within the range of concentrations of cocaine expected to be present during a cocaine overdose and, possibly, during the recreational use of cocaine. Thus specific nicotinic receptor subtypes may be expected to play a role in the toxicity of cocaine. The site to which cocaine binds on wild type and mutated nAChRs will be characterized functionally and chemically. The approaches adopted include (I) construction of receptors with varying subunit composition, chimeras, and subunits with peptide regions altered by site-directed mutations, and (ii) chemical kinetic measurements using a new technique developed by our laboratories, with a 50 to 100 micro-second time resolution that allows one to determine the effect of the drugs on the elementary steps of the receptor mediated reactions. The molecular mechanism, including knowledge of the concentraton at which nicotine and cocaine affect specific nAChRs, will provide a basis for mechanism-based design of therapeutic agents that will alleviate some effects of the drugs without themselves having deleterious effects. The knowledge gained is expected to contribute to the rational treatment of the millions of individuals adversely affected by cocaine and nicotine.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA011643-04
Application #
6378750
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Aigner, Thomas G
Project Start
1998-05-15
Project End
2002-03-31
Budget Start
2001-04-10
Budget End
2002-03-31
Support Year
4
Fiscal Year
2001
Total Cost
$181,257
Indirect Cost
Name
Cornell University
Department
Other Basic Sciences
Type
Schools of Veterinary Medicine
DUNS #
City
Ithaca
State
NY
Country
United States
Zip Code
14850
Alexander, John K; Sagher, Daphna; Krivoshein, Arcadius V et al. (2010) Ric-3 promotes alpha7 nicotinic receptor assembly and trafficking through the ER subcompartment of dendrites. J Neurosci 30:10112-26
Sivaprakasam, Kannan; Pagán, Oné R; Hess, George P (2010) Minimal RNA aptamer sequences that can inhibit or alleviate noncompetitive inhibition of the muscle-type nicotinic acetylcholine receptor. J Membr Biol 233:1-12
Pagan, One R; Sivaprakasam, Kannan; Oswald, Robert E (2007) Molecular properties of local anesthetics as predictors of affinity for nicotinic acetylcholine receptors. J Neurosci Res 85:2943-9
Krivoshein, Arcadius V; Hess, George P (2004) Mechanism-based approach to the successful prevention of cocaine inhibition of the neuronal (alpha 3 beta 4) nicotinic acetylcholine receptor. Biochemistry 43:481-9
Hess, George P (2003) Rapid chemical reaction techniques developed for use in investigations of membrane-bound proteins (neurotransmitter receptors). Biophys Chem 100:493-506
Francis, M M; Cheng, E Y; Weiland, G A et al. (2001) Specific activation of the alpha 7 nicotinic acetylcholine receptor by a quaternary analog of cocaine. Mol Pharmacol 60:71-9
Breitinger, H G; Geetha, N; Hess, G P (2001) Inhibition of the serotonin 5-HT3 receptor by nicotine, cocaine, and fluoxetine investigated by rapid chemical kinetic techniques. Biochemistry 40:8419-29
Francis, M M; Vazquez, R W; Papke, R L et al. (2000) Subtype-selective inhibition of neuronal nicotinic acetylcholine receptors by cocaine is determined by the alpha4 and beta4 subunits. Mol Pharmacol 58:109-19
Hess, G P; Ulrich, H; Breitinger, H G et al. (2000) Mechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK-801. Proc Natl Acad Sci U S A 97:13895-900